AzTrials
AzTrials

Cholecystitis, AcuteNCT03014817

Ultrasonically Activated Scalpel Versus Electrocautery Based Dissection in Acute Cholecystitis Trial

A study testing Ultrasonically activated scalpel and Electrocautery in people with Cholecystitis, Acute, run by Karolinska Institutet at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The present study aims at analyzing whether ultrasonic tissue coagulation dissection technique offers a smoother peri- and postoperative course and reduces the risk for conversion from laparoscopic to open surgery in acute cholecystectomy patients as compared to electrocautery in case of acute cholecystitis The study… Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Cholecystitis, Acute
What is being tested?
Ultrasonically activated scalpel and Electrocautery
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
1 siteSweden
Study dates
1 Oct 2019to 22 Mar 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Emergency laparoscopic cholecystectomy performed for cholecystitis
  • American Society of Anesthesiologists (ASA) score I-III

Who cannot join

  • Patients unable to express themselves in Swedish
  • Pregnancy
  • Previous open surgery in the upper abdomen
  • American Society of Anesthesiologists (ASA) score >III

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Karolinska University Hospital, Center for Digestive Diseases

    Stockholm, 14186

Other trials in Sweden

About this study

Official title: Ultrasonically Activated Scalpel Versus Electrocautery Based Dissection in Acute Cholecystitis. A Randomized, Double Blind, Multicenter Study

The present study aims at analyzing whether ultrasonic tissue coagulation dissection technique offers a smoother peri- and postoperative course and reduces the risk for conversion from laparoscopic to open surgery in acute cholecystectomy patients as compared to electrocautery in case of acute cholecystitis The study is performed as a double-blinded study on patients undergoing laparoscopic surgery for acute cholecystitis. Patients included in the study are randomized to surgery with either the traditional electrocautery based technique or ultrasonic scalpel based dissection.

Read the detailed description

Electrocautery is traditionally the method of choice for tissue dissection in laparoscopic cholecystectomy. As an alternative to electrocautery, the ultrasonically activated scalpel has proven to be an effective and safe instrument for the facilitation of dissection and to minimize blood loss in both open and laparoscopic surgery. Whereas electrocautery coagulates by burning at temperatures higher than 150ºC, the ultrasonic scalpel transforms the electric power into mechanical longitudinal vibration of the working part of the instrument by a piezoelectrical transducer. Accordingly, the former technique limits the heating- thermal necrosis effect on the tissue to the area just adjacent to the cutting line.

Since the relative-potential benefit of the ultrasonic scalpel is high in technically demanding surgery, the advantage may not be as pronounced in routine laparoscopic gallstone surgery, which can usually be done more uneventfully whichever equipment is used. Laparoscopic cholecystectomy for acute cholecystitis is, however, more demanding connected with longer operative time, more postoperative complications, greater risk of conversion to open cholecystectomy and longer postoperative stay. In addition, we know that operations for acute cholecystitis are associated with a higher risk for severe complications such as bile duct injury. The potential benefit from using the ultrasonic scalpel is thus even greater when doing surgery for cholecystitis.

In addition to this there are numerous important aspects on the safety in the implementation of the emergency cholecystectomy. Traditionally, most surgeons have chosen to operate these patients with laparoscopic technique, with the use of a so-called electrocautery hook, which usually allows tissue division with minimal blood loss. Further improvements in the dissection technique followed the introduction of ultrasonic tissue coagulation. This technique offers the option of performing these operations with even less blood loss, a more gentle handling of the inflamed tissue and a sealing of the tissue sections while the tissue is divided. Accordingly this ultrasonic tissue coagulation technique can theoretically be of significant advantage not the least when dividing acutely inflamed tissue like in acute cholecystitis with particular relevance for the dissection of the gallbladder from the liver bed, where bleeding and bile leakage often occurs. Moreover if the surgeon instead chooses to dissect the gallbladder from the doom and downwards, to the part that contains the cystic duct and cystic artery (Calots triangle), unique options can be offered to not only simplify the operation but also make it safer. This latter technique is called "fundus first".

The present study aims at analyzing whether ultrasonic tissue coagulation dissection technique combined with "fundus first" approach offers a smoother per and postoperative course in acute cholecystectomy patients as compared to the traditional way of performing the operation. Due to the lower risk of bleeding and better anatomical overview, the technique may also reduce the risk of having to convert the procedure for laparoscopic cholecystectomy to open cholecystectomy.

The study is performed as a double-blinded study on patients undergoing laparoscopic surgery for acute cholecystitis. Patients included in the study are randomized to surgery with either the traditional electrocautery based technique or ultrasonic scalpel based dissection with the "fundus first" approach.

The choice of dissection approach is determined by the randomization procedure, whether it is done from the triangle of Callot + electrocautery and upwards or from the gallbladder fundus and downwards by the use of the ultrasonic scalpel. Peroperative cholangiography is done routinely. The cystic duct is closed with a clip, not with the ultrasonic scalpel.

One month after surgery the patient is contacted by a telephone. In cases the questionnaires have not been returned yet, the patient is reminded about this. At the phone call the exact number of days of sick leave postoperatively and any adverse events occurring after discharge are recorded.

Being tested
Ultrasonically activated scalpel, Electrocautery
Medical subject headings
Cholecystitis, Acute

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasonically activated scalpelProcedure or surgery

    Dissection with ultrasonically activated scalpel

  • ElectrocauteryProcedure or surgery

    Dissection with electrocautery

Study groups in NCT03014817
Study groupRoleWhat they receive
Ultrasonically activated scalpelExperimentalDissection with ultrasonically activated scalpel. Direction of dissection undecided but by experience most naturally fundus first.
Receives: Procedure: Ultrasonically activated scalpel
ElectrocauteryActive comparatorDissection with electrocautery. Direction of dissection undecided but by experience most naturally cystic duct first.
Receives: Procedure: Electrocautery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative complications

    Postoperative complications registered according to Clavien-Dindo

    Measured: 30 days

Secondary outcomes (10)
  1. Operative time

    Time required to complete surgery

    Measured: 3 hours

  2. Level of technical complexity

    Level of technical complexity of the procedure as assessed by the surgeon

    Measured: 3 hours

  3. Technical performance

    Perioperative technical performance assessed by an independent observer

    Measured: 3 hours

  4. Postoperative stay

    Time from surgery to duscharge

    Measured: 14 days

  5. Sick leave

    Time from surgery to return to work

    Measured: 30 days

  6. Conversion rate

    Conversion from laparoscopic to open cholecystyectomy

    Measured: 3 hours

  7. Postoperative pain

    Daily assessments of pain on a visual analogue scale

    Measured: 7 days

  8. Postoperative inflammatory activity

    Daily measurements of c-reactive protein and leukocyte particle concentration

    Measured: 7 days

  9. Conversion rate

    Number of procedures converted to open cholecystectomy

    Measured: 3 hours

  10. Direct and indirect medical costs

    Analysis of health economics

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jan 2017 (estimated)
  2. Study start1 Oct 2019
  3. Primary completion22 Mar 2023
  4. Study completion22 Mar 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
180 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03014817
Sponsor's protocol ID
Ultrasonic scalpel trial
Status last verified
Apr 2024
First submitted
5 Jan 2017
Last updated
25 Apr 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Blohm M, Sandblom G, Enochsson L, Cengiz Y, Bayadsi H, Hennings J, Diaz Pannes A, Stenberg E, Bewo K, Osterberg J. Ultrasonic dissection versus electrocautery dissection in laparoscopic cholecystectomy for acute cholecystitis: a randomized controlled trial (SONOCHOL-trial). World J Emerg Surg. 2024 Nov 13;19(1):34. doi: 10.1186/s13017-024-00565-4.

    PubMed 39538278

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasonically activated scalpel and Electrocautery in people with Cholecystitis, Acute, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative complications (time frame: 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03014817, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in